1. EXECUTIVE SUMMARY
2. MARKET SNAPSHOT
2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation
3. BUSINESS LANDSCAPE
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter's Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations
4. TECHNOLOGICAL OUTLOOK
5. US AI IN DIAGNOSTICS MARKET BY COMPONENT
5.1. Introduction
5.2. Software
5.3. Hardware
6. US AI IN DIAGNOSTICS MARKET BY DIAGNOSTIC TYPE
6.1. Introduction
6.2. Radiology
6.3. Pathology
6.4. Cardiology
6.5. Oncology
6.6. Neurology
6.7. Others
7. US AI IN DIAGNOSTICS MARKET BY APPLICATION
7.1. Introduction
7.2. Disease Detection
7.3. Image Analysis
7.4. Risk Assessment
7.5. Predictive Analysis
7.6. Others
8. US AI IN DIAGNOSTICS MARKET BY END USER
8.1. Introduction
8.2. Hospitals And Clinics
8.3. Diagnostic Laboratories
8.4. Research Institutions
8.5. Others
9. COMPETITIVE ENVIRONMENT AND ANALYSIS
9.1. Major Players and Strategy Analysis
9.2. Market Share Analysis
9.3. Mergers, Acquisitions, Agreements, and Collaborations
9.4. Competitive Dashboard
10. COMPANY PROFILES
10.1. IBM Corporation
10.2. General Electric (GE) Company
10.3. Siemens Healthineers AG
10.4. Aidoc Medical Ltd.
10.5. Zebra Medical Vision Ltd.
10.6. Butterfly Network, Inc.
10.7. Viz.Ai, Inc.
10.8. Imagen Technologies, Inc.
10.9. Alivecor, Inc.
10.10. Pathai, Inc.
11. APPENDIX
11.1. Currency
11.2. Assumptions
11.3. Base and Forecast Years Timeline
11.4. Key benefits for the stakeholders
11.5. Research Methodology
11.6. Abbreviations
LIST OF FIGURES
LIST OF TABLES